That is not a bad analysis @whytee, I am always wondering why the current SP is at the current price. With the other company (I wont mention due to the risk of offending some) I have NO IDEA why it is being valued at about $140m with PMA FDA approval, and +us$100m worth of support from BARDA plus commitment to stock pile 5000 kits.I am also doing that for PNV, but no one can validate the current SP for PNV as yet. Hopefully management has a sales update soon. Or will we be made to wait til late Jan 2019?
Would you buy PNV for $370m with only $1.8m in sales last FY and no idea if sales will increase?
That is not a bad analysis @whytee, I am always wondering...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.030(1.27%) |
Mkt cap ! $1.616B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.43 | $2.32 | $5.953M | 2.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 29039 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 16702 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |